Network-based multiple sclerosis pathway analysis with GWAS data from 15,000 cases and 30,000 controls

Frauke Zipp, Adrian J. Ivinson, Jonathan L. Haines, Stephen Sawcer, Philip Dejager, Stephen L. Hauser, Jorge R. Oksenberg

Risultato della ricerca: Contributo su rivistaArticolo in rivistapeer review

Abstract

Multiple sclerosis (MS) is an inflammatory CNS disease with a substantial genetic component, originally mapped to only the human leukocyte antigen (HLA) region. In the last 5 years, a total of seven genome-wide association studies and one meta-analysis successfully identified 57 non-HLA susceptibility loci. Here, we merged nominal statistical evidence of association and physical evidence of interaction to conduct a protein-interaction-network-based pathway analysis (PINBPA) on two large genetic MS studies comprising a total of 15,317 cases and 29,529 controls. The distribution of nominally significant loci at the gene level matched the patterns of extended linkage disequilibrium in regions of interest. We found that products of genome-wide significantly associated genes are more likely to interact physically and belong to the same or related pathways. We next searched for subnetworks (modules) of genes (and their encoded proteins) enriched with nominally associated loci within each study and identified those modules in common between the two studies. We demonstrate that these modules are more likely to contain genes with bona fide susceptibility variants and, in addition, identify several high-confidence candidates (including BCL10, CD48, REL, TRAF3, and TEC). PINBPA is a powerful approach to gaining further insights into the biology of associated genes and to prioritizing candidates for subsequent genetic studies of complex traits.
Lingua originaleInglese
pagine (da-a)854-865
Numero di pagine12
RivistaAmerican Journal of Human Genetics
Volume92
Numero di pubblicazione6
DOI
Stato di pubblicazionePubblicato - 6 giu 2013
Pubblicato esternamente

Fingerprint

Entra nei temi di ricerca di 'Network-based multiple sclerosis pathway analysis with GWAS data from 15,000 cases and 30,000 controls'. Insieme formano una fingerprint unica.

Cita questo